Review: immunohematologic aspects of allogeneic hematopoietic progenitor cell transplantation
By:
Paid access
|May 2020References
- MarmontAM,DamasioEE,BacigalupoA,et al.A to O bone marrow transplantation in severe aplastic anemia: Dynamics of blood group conversion and demonstration of early dyserythropoiesis in the engrafted marrow. Br J Haematol 1977;36:511-8.
- Bryant E,Martin PJ. Documentation of engraftment and characterization of chimerism following hematopoietic cell transplantation. In: Blume KG, Forman S, Appelbaum FR, eds. Thomas’ hematopoietic cell transplantation. 3rd ed. Malden, Mass: Blackwell Publishing, 2004:234-43.
- Benson K, Fields K, Hiemenz J,et al. The plateletrefractory bone marrow transplant patient: prophylaxis and treatment of bleeding. Semin Oncol 1993;20(5):102-9.
- Ishida A, Handa M,Wakui M, Okamoto S, Kamakura M, Ikeda Y. Clinical factors inf luencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation—a prospective analysis. Transfusion 1998;38:839-47.
- O’Donnell MR. Blood group incompatibilities and haemolytic complications of hematopoietic cell transplantation. In: Blume KG, Forman S, Appelbaum FR, eds. Thomas’ hematopoietic cell transplantation. 3rd ed. Malden, Mass: Blackwell Publishing, 2004:824.
- Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004:459-60.
- Warkentin PI, Yomtovian R, Hurd D, et al. Severe delayed hemolytic transfusion reaction complicating an ABO-incompatible bone marrow transplantation. Vox Sang 1983;45:40-7.
- Lee JH, Lee JH, Choi SJ, et al. Changes of isoagglutinin titers after ABO-incompatible allogeneic stem cell transplantation. Br J Haematol 2003;120:702-10.
- Bolan CD, Leitman SF, Griffith LM, et al. Delayed donor RBC chimerism and pure RBC aplasia following major ABO-incompatible nonmyelo-ablative hematopoietic stem cell transplantation. Blood 2001;98:1687-94.
- Bar BM, Van Djik BA, Schattenberg A, de Man AJ, Kunst VA, de Witte T. Erythrocyte repopulation after major ABO-incompatible transplantation with lymphocyte-depleted bone marrow. Bone Marrow Transplant 1995;16:793-9.
- Gmur J, Burger J, Schaffner A, et al. Pure RBC aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990;75:290-5.
- Sniecinsky IJ, Oien L, Petz LD, Blume KG. Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 1988;45:530-4.
- Witherspoon RP, Storb R, Ochs HD, et al. Recovery of antibody production in human allogeneic marrow graft recipients: inf luence of time posttransplantation, the presence or absence of graft-versus-host disease, and antithymocyte globulin treatment. Blood 1981;58:360-8.
- Ramsey G, Sherman LA. Transfusion therapy in solid organ transplantation. Hematol Oncol Clin North Am 1994;8:1117-29.
- Hows J, Beddow K, Gordon-Smith E, et al. Donor-derived RBC antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 1986;67:177-81.
- Rowley S, Braine H. Probable hemolysis following minor ABO incompatible marrow transplantation (IMT) (abstract). Blood 1982;60(Suppl. 1):171.
- Gajewski JL, Petz LD, Calhoun L, et al. Hemolysis of transfused O RBCs in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood 1992;79:3076-85.
- Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004:463-4.
- Sokol RJ, Stamps R, Booker DJ, et al. Posttransplant immune-mediated hemolysis.Transfusion 2002;42: 198-204.
- Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004:465.
- Bensinger WI, Buckner CD, Thomas ED, Clift RA. ABO-incompatible marrow transplants. Transplantation 1982;33:427-9.
- Korbling M, Huh YO, Durett A, et al. Allogeneic blood stem cell transplantation: peripheralization and yield of primitive donor-derived hematopoietic progenitor cells (CD341 Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995;86:2842-8.
- Ramsey G. RBC antibodies arising from solid organ transplants. Transfusion 1991;31:76-86.
- Salmon JP, Michaux S, Hermanne JP, et al. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion 1999;39:824-7.
- Bolan CD, Childs RW, Procter JL,Barrett AJ, Leitman SF. Massive haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO-incompatibility B J Haematol 2001;112:787-95.
- Yomtovian R, Chau CJ, Hendrix D, et al. Lack of isohemagglutinin production following minor ABO incompatible umbilical cord blood transplantation (abstract). Transfusion 2002;42:1s-2s.
- Sandmaier BM, Storb R. Nonmyeloablative therapy and hematopoietic cell transplantation for hematologic disorders. In: Blume KG, Forman S, Appelbaum FR, eds. Thomas’ hematopoietic cell transplantation. 3rd ed. Malden, Mass: Blackwell Publishing, 2004:1164-76.
- Worel N, Greinix HT, Keil F, et al. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion 2002;42:1293-1301.
- Mielcarek M, Zaucha JM, Sandmaier B, et al. Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibility. Br J Haematol 2002;116:500-1.
- Greeno EW, Perry EH, Ilstrup SJ, Weisdorf DJ. Exchange transfusion the hard way: Massive hemolysis following transplantation of bone marrow with minor ABO incompatibility. Transfusion 1996;36:71-4.
- Benjamin RJ, Anton JH. ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity. Transfusion 1999;39:1273-4.
- Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98:2043-51.
- Mielcarek M, Leisenring W, Torok-Storb B, Storb R. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood 2000; 96:1150-6.
- Heal J, Kenmotsu N, Rowe JM, Blumberg N. A possible survival advantage in adults with acute leukemia receiving ABO-identical platelet transfusions. Am J Hematol 1994;45:189-90.
- Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH. ABO-incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 1999;39:179-87.
- Goldman J, Liesveld J, Nichols D, Heal J, Blumberg N. ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation. Leuk Res 2003;27:489-91.
- Stussi G, Muntwyler J, Passweg JR, et al. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantations. Bone Marrow Transplant 2002;30:87-93.
- Mehta J, Powles R, Sirohi B, et al. Does donorrecipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? Bone Marrow Transplant 2002;29:853-9.
- Storb R, Thomas ED, Weiden PL, et al. Aplastic anemia treated by allogeneic bone marrow transplantation: A report on 49 new cases from Seattle. Blood 1976;48:817-41.
- Lasky L,Warkentin P, Ramsey N, Kersey J, McGlave P, McCullough J. Hemotherapy in patients undergoing blood group incompatible bone marrow transfusion. Transfusion 1983;23:277-85.
- Bacigalupo A,Van Lint MT, Occhini D, et al. ABO compatibility and acute graft-versus-host disease allogeneic bone marrow transplantation. Transplantation 1988;45:1091-4.
- Barone B, Cordeiro de Paiva TM, da Silva Bouzas LF. ABO system incompatibility and graft versus host disease (GVHD) frequency in bone marrow transplanted patients (abstract). Blood 2001;98: 374b.
- Ting A,Pun A, Dodds AJ, Atkinson K, Biggs JC. RBC alloantibodies produced after bone marrow transplantation. Transfusion 1987;27:145-7.
- De la Rubia J, Arriaga F, Andreu R, et al. Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor? Transfusion 2001;41:106-110.
- Franchini M, Gandini G, Aprili G. Non-ABO RBC alloantibodies after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004;33:1169-72.
- Young PP, Goodnough LT,Westervelt P, DiPersio JF. Immune hemolysis involving non-ABO/RhD alloantibodies following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;27:1305-10.
- Warkentin PI, Hilden JM, Kersey JH, Ramsey NKC, McCullough J. Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch. Vox Sang 1985;48:89-104.
- Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004:468.
- Chen FE, Owen I, Savage D, et al. Late onset haemolysis and RBC autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant 1997;19:491-5.
- Drobyski WR, Potluri J, Sauer D, Gottschall JL. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant 1996:17:1093-9.
- O’Brien TA, Eastlund T, Peters C,et al. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematology (in press).
DOI: https://doi.org/10.21307/immunohematology-2019-453 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 217 - 225
Published on: May 18, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2020 V. Laroche, D.T. Eastlund, J. Mccullough, published by American National Red Cross
This work is licensed under the Creative Commons License.